The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
NU HLDGS LTD ORD SHS CL A G6683N103   13,842,186 1,909,267 SH   SOLE   1,909,267 0 0
ISHARES TR CORE S&P500 ET 464287200   60,355,528 140,548 SH   SOLE   140,548 0 0
AKERO THERAPEUTICS INC COM 00973Y108   5,251,013 103,816 SH   SOLE   103,816 0 0
89BIO INC COM 282559103   1,953,407 126,516 SH   SOLE   126,516 0 0
MADRIGAL PHARMACEUTICALS INC COM 558868105   5,861,023 40,133 SH   SOLE   40,133 0 0